BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38844356)

  • 1. Massive arterial and venous thrombosis from smouldering multiple myeloma: further evidence for monoclonal gammopathy of thrombotic significance.
    Kun J; Hunter J
    BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38844356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.
    Kristinsson SY; Pfeiffer RM; Björkholm M; Goldin LR; Schulman S; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
    Blood; 2010 Jun; 115(24):4991-8. PubMed ID: 20299513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
    Za T; De Stefano V; Rossi E; Petrucci MT; Andriani A; Annino L; Cimino G; Caravita T; Pisani F; Ciminello A; Torelli F; Villivà N; Bongarzoni V; Rago A; Betti S; Levi A; Felici S; Gentilini F; Calabrese E; Leone G;
    Br J Haematol; 2013 Mar; 160(5):673-9. PubMed ID: 23240810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal gammopathy-associated pure red cell aplasia.
    Korde N; Zhang Y; Loeliger K; Poon A; Simakova O; Zingone A; Costello R; Childs R; Noel P; Silver S; Kwok M; Mo C; Young N; Landgren O; Sloand E; Maric I
    Br J Haematol; 2016 Jun; 173(6):876-83. PubMed ID: 26999424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
    Cowan A; Ferrari F; Freeman SS; Redd R; El-Khoury H; Perry J; Patel V; Kaur P; Barr H; Lee DJ; Lightbody E; Downey K; Argyelan D; Theodorakakou F; Fotiou D; Liacos CI; Kanellias N; Chavda SJ; Ainley L; Sandecká V; Pospíšilová L; Minarik J; Jungova A; Radocha J; Spicka I; Nadeem O; Yong K; Hájek R; Kastritis E; Marinac CR; Dimopoulos MA; Get G; Trippa L; Ghobrial IM
    Lancet Haematol; 2023 Mar; 10(3):e203-e212. PubMed ID: 36858677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
    Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
    Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic breast cancer and monoclonal gammopathy of undetermined significance resembling multiple myeloma.
    Muehlschlegel P; Gillmore R; Pomplun S
    BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37348925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study.
    Emery A; Moore S; Crowe J; Murray J; Peacock O; Thompson D; Betts F; Rapps S; Ross L; Rothschild-Rodriguez D; Arana Echarri A; Davies R; Lewis R; Augustine DX; Whiteway A; Afzal Z; Heaney J; Drayson MT; Turner JE; Campbell JP
    BMC Cancer; 2024 Feb; 24(1):174. PubMed ID: 38317104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of monoclonal gammopathy.
    Gandara DR; Mackenzie MR
    Med Clin North Am; 1988 Sep; 72(5):1155-67. PubMed ID: 3137401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma.
    Kristinsson SY; Fears TR; Gridley G; Turesson I; Mellqvist UH; Björkholm M; Landgren O
    Blood; 2008 Nov; 112(9):3582-6. PubMed ID: 18559977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA
    Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin A monoclonal gammopathy in two horses with multiple myeloma.
    Pusterla N; Stacy BA; Vernau W; De Cock HE; Magdesian KG
    Vet Rec; 2004 Jul; 155(1):19-23. PubMed ID: 15264485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior Mesenteric Arterial and Venous Thrombosis in COVID-19.
    Amaravathi U; Balamurugan N; Muthu Pillai V; Ayyan SM
    J Emerg Med; 2021 May; 60(5):e103-e107. PubMed ID: 33581991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomes.
    Garderet L; Al Hariri M; Wasielica-Poslednik J; Munder M; Kormányos K; Pena C; Gozzetti A; Zhou X; Waszczuk-Gajda A; Rosinol L; Mikala G; Krzystanski M; Lisch W; Vesole D; Szentmáry N; Jurczyszyn A
    Leuk Lymphoma; 2022 Apr; 63(4):984-990. PubMed ID: 34823428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystalglobulinemia manifested as acute renal failure and thrombotic vasculopathy.
    Gómez-Lechón Quirós L; Acosta De La Vega ME; Compán Fernández O; Pastor Navarro S; Montilla Morales C; Moyano Bueno D; Martín Centellas J; Santos-Briz Terrón A; Hidalgo Calleja C
    Rheumatol Int; 2020 Aug; 40(8):1327-1332. PubMed ID: 32533290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of thrombotic microangiopathy and nodular sclerosis in light chain deposition disease.
    Kanjanabuch T; Bunruang R; Srisawat N; Lewsuwan S; Kittikovit V; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S248-52. PubMed ID: 17044479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
    Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.